Thrombolysis in Pediatric Stroke (TIPS)

Stopped early · Phase 1

Conditions studied: Stroke

In brief

Thrombolysis in Pediatric Stroke (TIPS) is a five-year multi-center international safety and dose-finding study of intravenous (IV) tPA in children with acute ischemic stroke (AIS) to determine the maximal safe dose of intravenous Tissue Plasminogen Activator (IV-tPA) among three doses (0.75. 0.9, 1.0 mg/kg) for children age 2-17 years within 4.5 hours from onset of acute AIS.

Key facts

Study ID: NCT01591096
Run by: Seattle Children's Hospital
People needed: 1
Starts: 2012-10-01
Expected to finish: 2013-12-01
Last updated by the study team: 2018-05-25

Who can join

Age: 2 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

Where it is running

Stanford University and Lucile Packard Children's Hospital at Stanford — Palo Alto, California, United States
Children's Hospital Colorado — Aurora, Colorado, United States
Massachusetts General Hospital — Boston, Massachusetts, United States
Boston Children's Hospital — Boston, Massachusetts, United States
Columbia University Medical Center — New York, New York, United States
Cleveland Clinic — Cleveland, Ohio, United States
Children's Hospital of Pittsburgh — Pittsburgh, Pennsylvania, United States
Monroe Carell Jr. Children's Hospital at Vanderbilt — Nashville, Tennessee, United States
Children's Medical Center at Dallas — Dallas, Texas, United States
Cook Children's Medical Center — Fort Worth, Texas, United States
University of Texas Medical School at Houston — Houston, Texas, United States
The University of Utah and Primary Children's Medical Center — Salt Lake City, Utah, United States
Seattle Children's Hospital — Seattle, Washington, United States
Alberta Children's Hospital — Calgary, Alberta, Canada
Hospital for Sick Children — Toronto, Ontario, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.